NDC 0006-3941

EMEND

Fosaprepitant Dimeglumine

EMEND is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Fosaprepitant Dimeglumine.

Product ID0006-3941_46054db2-5cc3-4a8d-86a3-f11f687f3d30
NDC0006-3941
Product TypeHuman Prescription Drug
Proprietary NameEMEND
Generic NameFosaprepitant Dimeglumine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2010-11-12
Marketing CategoryNDA / NDA
Application NumberNDA022023
Labeler NameMerck Sharp & Dohme Corp.
Substance NameFOSAPREPITANT DIMEGLUMINE
Active Ingredient Strength150 mg/5mL
Pharm ClassesNeurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0006-3941-32

1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3941-32) > 5 mL in 1 VIAL, SINGLE-DOSE (0006-3941-01)
Marketing Start Date2010-11-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0006-3941-01 [00006394101]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA022023
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-11-12

NDC 0006-3941-32 [00006394132]

EMEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA022023
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-11-12
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
FOSAPREPITANT DIMEGLUMINE150 mg/5mL

OpenFDA Data

SPL SET ID:44f634f4-b794-4d55-8ab7-037fdef8ff0f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1731077
  • 1731080
  • 1731075
  • 1731082
  • UPC Code
  • 0300063884327
  • 0300063941327
  • Pharmacological Class

    • Neurokinin 1 Antagonists [MoA]
    • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 3A4 Inducers [MoA]

    NDC Crossover Matching brand name "EMEND" or generic name "Fosaprepitant Dimeglumine"

    NDCBrand NameGeneric Name
    0006-0461EMENDaprepitant
    0006-0462EMENDaprepitant
    0006-0464EMENDaprepitant
    0006-3061EMENDFOSAPREPITANT DIMEGLUMINE
    0006-3066EMENDaprepitant
    0006-3862EMENDaprepitant
    0006-3941EMENDEMEND
    42254-160EMENDEMEND

    Trademark Results [EMEND]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EMEND
    EMEND
    98452421 not registered Live/Pending
    EMEND, LLC
    2024-03-15
    EMEND
    EMEND
    90879357 not registered Live/Pending
    EMEND, LLC
    2021-08-12
    EMEND
    EMEND
    90879262 not registered Live/Pending
    EMEND, LLC
    2021-08-12
    EMEND
    EMEND
    90816895 not registered Live/Pending
    EMEND, LLC
    2021-07-08
    EMEND
    EMEND
    88511573 not registered Live/Pending
    Lonza Ltd.
    2019-07-12
    EMEND
    EMEND
    78449789 3154890 Live/Registered
    Medion Corporation
    2004-07-13
    EMEND
    EMEND
    76254977 2725335 Dead/Cancelled
    Merck & Co., Inc.
    2001-05-10
    EMEND
    EMEND
    75292656 2417822 Live/Registered
    MERCK & CO., Inc.
    1997-05-15
    EMEND
    EMEND
    74619649 2032756 Dead/Cancelled
    CLINITEX MEDICAL CORPORATION
    1995-01-10

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.